From the Department of Radiology, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Madison, WI 53792-3252 (A.M.F.); Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.A.M.); and Department of Radiology and Biomedical Imaging, University of California-San Francisco School of Medicine, San Francisco, Calif (B.N.J.).
Radiology. 2017 Nov;285(2):358-375. doi: 10.1148/radiol.2017170180.
The use of neoadjuvant systemic therapy in the treatment of breast cancer patients is increasing beyond the scope of locally advanced disease. Imaging provides important information in assessing response to therapy as a complement to conventional tumor measurements via physical examination. The purpose of this article is to discuss the advantages and limitations of current assessment methods, as well as review functional and molecular imaging approaches being investigated as emerging techniques for evaluating neoadjuvant therapy response for patients with primary breast cancer. RSNA, 2017.
新辅助全身治疗在乳腺癌患者中的应用正在超出局部晚期疾病的范围。成像技术通过体格检查以外的常规肿瘤测量方法为评估治疗反应提供了重要信息。本文旨在讨论当前评估方法的优缺点,并综述正在研究的功能和分子成像方法,这些方法被认为是评估原发性乳腺癌患者新辅助治疗反应的新兴技术。
RSNA,2017.